T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients (Q45876112)

17 December 2017

title

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients (English)

1 reference

17 December 2017

0 references

0 references

Riddell SR

1

1 reference

17 December 2017

Elliott M

2

1 reference

17 December 2017

Lewinsohn DA

3

1 reference

17 December 2017

Gilbert MJ

4

1 reference

17 December 2017

Wilson L

5

1 reference

17 December 2017

Manley SA

6

1 reference

17 December 2017

Lupton SD

7

1 reference

17 December 2017

Overell RW

8

1 reference

17 December 2017

Reynolds TC

9

1 reference

17 December 2017

Corey L

10

1 reference

17 December 2017

Greenberg PD

11

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

2

1 reference

17 December 2017

page(s)

216-223

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/nm0296-216

exact match

0 references

cites work

Human gene therapy comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

A viral inhibitor of peptide transporters for antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Herpes simplex virus turns off the TAP to evade host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

Limiting dilution assays. Experimental design and statistical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Persistence of Replication-Deficient Adenovirus-Mediated Gene Transfer in Lungs of Immune-Deficient (nu/nu) Mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, Janu

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Principles for adoptive T cell therapy of human viral diseases

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Targeting of an inducible toxic phenotype in animal cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Self-nonself discrimination by T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington

1 reference

https://api.crossref.org/works/10.1038%2FNM0296-216

7 January 2021

Identifiers

DOI

10.1038/NM0296-216

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017